ASND

As of 2026-09-11, ASND scores 55out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. ASND trades at $263.51, 24% above the band ceiling.

ASND scores 55 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 55. Its strongest factor is quality at 74 (strong), where earnings quality and balance-sheet strength stand out, followed by momentum at 54. The weakest is volume at 43, where volume gives little confirmation. Among Healthcare stocks it ranks in roughly the top 20% of the Healthcare names the model scores.

On valuation, ASND is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 57. Same-sector names the model rates nearby include HALO, THC, HNGE.

This is a descriptive factor read on ASND, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where ASND sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for ASND runs $145.39–$212.46. Current price $263.51 sits 24% above the band ceiling. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-11.